Pharma

Transforming health through business and innovation.

A new genetic test can predict how well Ozempic will work for patients

A new genetic test can predict how well Ozempic will work for patients

By

UpdatedMay 20, 2024

Hims & Hers is now selling Ozempic-like weight loss drugs for $199

Hims & Hers is now selling Ozempic-like weight loss drugs for $199

By

PublishedMay 20, 2024

The rise of Ozempic: How a diabetes medication sparked the weight loss drug revolution

The rise of Ozempic: How a diabetes medication sparked the weight loss drug revolution

By

PublishedMay 20, 2024

Weight loss pills, Ozempic's big fan, and Merck's skin cancer drug: Pharma news roundup

Weight loss pills, Ozempic's big fan, and Merck's skin cancer drug: Pharma news roundup

By

PublishedMay 17, 2024

Eli Lilly says its experimental weekly insulin works just as well as daily doses

Eli Lilly says its experimental weekly insulin works just as well as daily doses

By

UpdatedMay 16, 2024

An experimental weight loss drug helped users lose 18% of their weight in an early trial

An experimental weight loss drug helped users lose 18% of their weight in an early trial

By

UpdatedMay 16, 2024

A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says

A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says

By

UpdatedMay 15, 2024

People taking the weight loss drug Wegovy are keeping the weight off for years, study says

People taking the weight loss drug Wegovy are keeping the weight off for years, study says

By

PublishedMay 14, 2024

Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side effects

Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side effects

By

PublishedMay 13, 2024

1 in 8 Americans have taken drugs like Ozempic — but mostly not for weight loss

1 in 8 Americans have taken drugs like Ozempic — but mostly not for weight loss

By

UpdatedMay 10, 2024

Novo Nordisk struck a $600 million deal to find the next weight loss wonder drug

Novo Nordisk struck a $600 million deal to find the next weight loss wonder drug

By

PublishedMay 9, 2024

The FTC is challenging 'junk' drug patents. Here's what they are and why they matter

The FTC is challenging 'junk' drug patents. Here's what they are and why they matter

By

UpdatedMay 8, 2024

AstraZeneca is pulling its COVID-19 vaccine

AstraZeneca is pulling its COVID-19 vaccine

By

UpdatedMay 8, 2024

Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how

Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how

By

UpdatedMay 8, 2024

Amgen teased trial results for its potential Ozempic competitor — and the stock surged 13%

Amgen teased trial results for its potential Ozempic competitor — and the stock surged 13%

By

PublishedMay 3, 2024

Wegovy sales surge, COVID vax sales sink, and 'junk' patents: Pharma news roundup

Wegovy sales surge, COVID vax sales sink, and 'junk' patents: Pharma news roundup

By

PublishedMay 3, 2024

Ozempic maker Novo Nordisk denies flooding market with 'junk' patents after FTC challenge

Ozempic maker Novo Nordisk denies flooding market with 'junk' patents after FTC challenge

By

PublishedMay 2, 2024

Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales

Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales

By

UpdatedMay 2, 2024

Wegovy sales more than doubled as the weight loss drug boom keeps powering Novo Nordisk

Wegovy sales more than doubled as the weight loss drug boom keeps powering Novo Nordisk

By

UpdatedMay 2, 2024

Ozempic is so hot right now that subsidies for the drug are being cut in Novo Nordisk's home country

Ozempic is so hot right now that subsidies for the drug are being cut in Novo Nordisk's home country

By

UpdatedMay 1, 2024

Advertisement